Home › Funds › RTW INVESTMENTS, LP › MDGL

RTW INVESTMENTS, LP position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

RTW INVESTMENTS, LP reported holding 312,817 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$157.6M, representing 1.59% of its reported portfolio and ranking #21 among its reported holdings. RTW INVESTMENTS, LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)312.82K sh
Reported value held$157.65M
Portfolio Weight1.59%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's MDGL position evolved

RTW INVESTMENTS, LP first disclosed a stake in MDGL in Q3 2023 at 309,485 shares (US$45.2M). The position peaked in Q4 2025 at 1,993,687 shares, worth US$1.16B. Across 13 filings, RTW INVESTMENTS, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 312,817 shares valued at US$157.6M — a reduction of -1,680,870 shares quarter over quarter.. Notable position changes include a 163% increase in Q4 2023 (shares rose 15% over the following quarter), a 383% increase in Q2 2024 (shares fell 24% over the following quarter), a 84% trim in Q3 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 309.49K $45.20M New
Q4 2023 815.19K $188.62M Add
Q1 2024 397.05K $106.03M Reduce
Q2 2024 1.92M $536.75M Add
Q3 2024 1.99M $423.10M Add
Q4 2024 1.99M $615.19M Hold
Q1 2025 1.99M $660.37M Hold
Q2 2025 1.99M $603.37M Hold
Q3 2025 1.99M $914.42M Hold
Q4 2025 1.99M $1.16B Hold
Q1 2026 1.99M $1.04B Hold
Q2 2026 1.99M $1.07B Hold
Q3 2026 312.82K $157.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), Janus Henderson Group (US$1.05B), Jupiter Topco LLC (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has RTW INVESTMENTS, LP held MDGL?

RTW INVESTMENTS, LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RTW INVESTMENTS, LP's current position in MDGL?

As of Q3 2026, RTW INVESTMENTS, LP holds 312.82K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $157.65M, representing 1.59% of its reported portfolio and ranking #21.

Has RTW INVESTMENTS, LP been buying or selling MDGL?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP reduced its position in MDGL. The position peaked in Q4 2025 at 1.99M shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Janus Henderson Group, Jupiter Topco LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.